Review
doi: 10.1016/j.micinf.2012.01.012.
Epub 2012 Feb 4.
Streptococcus pneumoniae: the evolution of antimicrobial resistance to beta-lactams, fluoroquinolones and macrolides
Affiliations
- PMID: 22342898
- DOI: 10.1016/j.micinf.2012.01.012
Item in Clipboard
Review
Streptococcus pneumoniae: the evolution of antimicrobial resistance to beta-lactams, fluoroquinolones and macrolides
Microbes Infect.
2012 Jul.
Free article
Abstract
Multi drug resistant Streptococcus pneumoniae constitute a major public health concern worldwide. In this review we discuss how the transformable nature of the pneumococcus, in parallel with antimicrobial induced stress, contributes to the evolution of antimicrobial resistance; and how the introduction of the pneumococcal conjugate vaccine has affected the situation.
Copyright © 2012 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
Similar articles
-
Comparative evaluation of synergy of combinations of beta-lactams with fluoroquinolones or a macrolide in Streptococcus pneumoniae.J Antimicrob Chemother. 2011 Apr;66(4):845-9. doi: 10.1093/jac/dkr016. Epub 2011 Feb 3. J Antimicrob Chemother. 2011. PMID: 21393187
-
Epidemiology of antibiotic-resistant Streptococcus pneumoniae strains in Far East Russia.Int J Antimicrob Agents. 2004 Jun;23(6):641-2. doi: 10.1016/j.ijantimicag.2004.03.005. Int J Antimicrob Agents. 2004. PMID: 15194139 No abstract available.
-
The antimicrobial resistance profile of Streptococcus pneumoniae.Clin Microbiol Infect. 2009 Apr;15 Suppl 3:7-11. doi: 10.1111/j.1469-0691.2009.02724.x. Clin Microbiol Infect. 2009. PMID: 19366363 Review.
-
In vitro activity of beta-lactams, macrolides, telithromycin, and fluoroquinolones against clinical isolates of Streptococcus pneumoniae: correlation between drug resistance and genetic characteristics.J Infect Chemother. 2005 Oct;11(5):262-4. doi: 10.1007/s10156-005-0405-z. J Infect Chemother. 2005. PMID: 16258826
-
Antimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the United States.Clin Infect Dis. 2001 Sep 15;33 Suppl 3:S187-92. doi: 10.1086/321847. Clin Infect Dis. 2001. PMID: 11524718 Review.
Cited by
-
A Review of the Resistance Mechanisms for β-Lactams, Macrolides and Fluoroquinolones among Streptococcus pneumoniae.Medicina (Kaunas). 2023 Oct 31;59(11):1927. doi: 10.3390/medicina59111927. Medicina (Kaunas). 2023. PMID: 38003976 Free PMC article. Review.
-
A novel gene amplification causes upregulation of the PatAB ABC transporter and fluoroquinolone resistance in Streptococcus pneumoniae.Antimicrob Agents Chemother. 2015;59(6):3098-108. doi: 10.1128/AAC.04858-14. Epub 2015 Mar 16. Antimicrob Agents Chemother. 2015. PMID: 25779578 Free PMC article.
-
The Crisis of Macrolide Resistance in Pneumococci in Latin America.Am J Trop Med Hyg. 2024 Jul 30;111(4):756-764. doi: 10.4269/ajtmh.23-0913. Print 2024 Oct 2. Am J Trop Med Hyg. 2024. PMID: 39084209 Free PMC article. Review.
-
Panel 4: Recent advances in understanding the natural history of the otitis media microbiome and its response to environmental pressures.Int J Pediatr Otorhinolaryngol. 2020 Mar;130 Suppl 1(Suppl 1):109836. doi: 10.1016/j.ijporl.2019.109836. Epub 2019 Dec 18. Int J Pediatr Otorhinolaryngol. 2020. PMID: 31879084 Free PMC article. Review.
-
Antibody Treatment against Angiopoietin-Like 4 Reduces Pulmonary Edema and Injury in Secondary Pneumococcal Pneumonia.mBio. 2019 Jun 4;10(3):e02469-18. doi: 10.1128/mBio.02469-18. mBio. 2019. PMID: 31164474 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
